Americans are paying billions to take drugs that don't work

By Bloomberg
| April 16, 2024

Companies are increasingly using fast-track approval processes to get unproven treatments to patients.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...